Shi-Young Park

448 total citations
8 papers, 385 citations indexed

About

Shi-Young Park is a scholar working on Molecular Biology, Pharmacology and Cell Biology. According to data from OpenAlex, Shi-Young Park has authored 8 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Pharmacology and 2 papers in Cell Biology. Recurrent topics in Shi-Young Park's work include Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Shi-Young Park is often cited by papers focused on Cancer, Hypoxia, and Metabolism (2 papers), Angiogenesis and VEGF in Cancer (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Shi-Young Park collaborates with scholars based in South Korea. Shi-Young Park's co-authors include Yung-Jin Kim, Eui-Yeun Yi, Joo‐Won Jeong, Won‐Jun Jang, Yunjin Jung, Il Yun, Mi‐Ae Yoo, Hye‐Ock Jang, Ju Youn Lee and Kyu‐Sil Choi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and Cancer Letters.

In The Last Decade

Shi-Young Park

8 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shi-Young Park South Korea 8 153 116 86 75 64 8 385
Zhi‐Min Sun China 11 126 0.8× 42 0.4× 50 0.6× 86 1.1× 33 0.5× 12 380
Francisca M. Santandreu Spain 7 200 1.3× 31 0.3× 59 0.7× 140 1.9× 56 0.9× 8 371
José M. Carrascosa Spain 9 216 1.4× 127 1.1× 137 1.6× 216 2.9× 29 0.5× 13 508
Chan Wu China 11 219 1.4× 33 0.3× 47 0.5× 85 1.1× 48 0.8× 27 513
Chrysovalantou E. Xirouchaki Australia 10 202 1.3× 54 0.5× 65 0.8× 138 1.8× 31 0.5× 14 423
Beth Griesel United States 11 327 2.1× 28 0.2× 85 1.0× 216 2.9× 71 1.1× 16 499
Jacek Turyn Poland 13 244 1.6× 34 0.3× 65 0.8× 88 1.2× 135 2.1× 21 448
Mireia Jové Spain 10 341 2.2× 29 0.3× 165 1.9× 312 4.2× 53 0.8× 10 568
Zhihong Wu China 12 111 0.7× 18 0.2× 120 1.4× 99 1.3× 40 0.6× 28 437
Kelly L. Stromsdorfer United States 8 130 0.8× 38 0.3× 109 1.3× 238 3.2× 21 0.3× 8 432

Countries citing papers authored by Shi-Young Park

Since Specialization
Citations

This map shows the geographic impact of Shi-Young Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Young Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Young Park more than expected).

Fields of papers citing papers by Shi-Young Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi-Young Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Young Park. The network helps show where Shi-Young Park may publish in the future.

Co-authorship network of co-authors of Shi-Young Park

This figure shows the co-authorship network connecting the top 25 collaborators of Shi-Young Park. A scholar is included among the top collaborators of Shi-Young Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi-Young Park. Shi-Young Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Park, Shi-Young, et al.. (2011). Ethyl pyruvate, an anti-inflammatory agent, inhibits tumor angiogenesis through inhibition of the NF-κB signaling pathway. Cancer Letters. 303(2). 150–154. 23 indexed citations
3.
Choi, Jae‐Sun, Shi-Young Park, Eui-Yeun Yi, Yung-Jin Kim, & Joo‐Won Jeong. (2011). Coenzyme Q10 Decreases Basic Fibroblast Growth Factor (bFGF)-Induced Angiogenesis by Blocking ERK Activation. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 19(10). 455–461. 11 indexed citations
4.
Park, Shi-Young, Won‐Jun Jang, Eui-Yeun Yi, et al.. (2010). Melatonin suppresses tumor angiogenesis by inhibiting HIF-1α stabilization under hypoxia. Journal of Pineal Research. 48(2). 178–184. 161 indexed citations
5.
Kim, Su-Ryun, Soo‐Kyung Bae, Kyu‐Sil Choi, et al.. (2007). Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2. Biochemical and Biophysical Research Communications. 357(1). 150–156. 132 indexed citations
6.
Yi, Eui-Yeun, et al.. (2006). KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis. Experimental & Molecular Medicine. 38(5). 502–508. 12 indexed citations
7.
Lee, Soo-Jung, et al.. (2002). Osmolarity hypersensitivity ofhog1deleted mutants is suppressed by mutation inKSS1in budding yeastSaccharomyces cerevisiae. FEMS Microbiology Letters. 209(1). 9–14. 7 indexed citations
8.
Park, Shi-Young, et al.. (2001). Mutation in PMR1, a Ca2+-ATPase in Golgi, Confers Salt Tolerance in Saccharomyces cerevisiae by Inducing Expression of PMR2, an Na+-ATPase in Plasma Membrane. Journal of Biological Chemistry. 276(31). 28694–28699. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026